Charles River was happy to return as a Platinum Sponsor and participated in several presentations, which includes symposia, continuing education, exhibitor hosted sessions, and multiple posters. We are ready to help you with your toxicology, and drug development goals and you can download copies of our posters from the annual meeting.
|
Comparisons of Historical Control Clinical Pathology Data from Sprague-Dawley Rats and Wistar Han Rats of Similar Ages Chronic Intrathecal Administration in the Sprague-Dawley Rat Characterization of Focal Chorioretinal Atrophy in Sprague-Dawley Rats as a New Model of Human Geographic Atrophy, the Late Stage of Dry Age-related Macular Degeneration Cerebrospinal Administration in the C57Bl6 Mouse Using the Intracerebroventricular Route Comparison of FGF Receptor 1 Klotho Beta Dependent Agonist in CD1 and C57BL/6J DIO Mice Re-Evaluation of Discordant Results in Related OECD TG471 Tester Strains |
Explore some of our capabilities.
It’s impossible to anticipate the challenges you’ll face on the journey to market. Your best asset is a nimble, versatile nonclinical partner who knows how to scale scientific hurdles, overcome regulatory snags, and clear a path to approval. Combining all the advantages of a world-leading CRO with flexible, responsive service and programs tailored to your molecule, whether it's a human or veterinary drug, an agro- or industrial chemical, or a food additive, Charles River delivers.